Patent: 8,187,612
✉ Email this page to a colleague
Summary for Patent: 8,187,612
Title: | Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle |
Abstract: | A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of botulinum toxin types A, B, C, D, E, F and G. |
Inventor(s): | Aoki; Kei Roger (Coto De Caza, CA), Grayston; Michael W. (Irvine, CA), Carlson; Steven R. (San Mateo, CA), Leon; Judith M. (San Juan Capistrano, CA) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 10/726,904 |
Patent Claims: | see list of patent claims |
Details for Patent 8,187,612
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | December 08, 2000 | ⤷ Sign Up | 2013-12-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |